January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Citi raised the firm’s price target on SoFi Technologies (SOFI) to $18 from $12.50 and keeps a Buy rating on the shares as part of a 2025 ...

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.42% to 42,473.91 while the NASDAQ ...

Truist Financial analyst Les Sulewski maintained a Hold rating on ANI Pharmaceuticals (ANIP – Research Report) today. The company’s shares ...

Although aluminium prices for U.S. consumers have risen since Donald Trump's election win, the rise has been muted, ...

Drones As A Strategic Industry Drones have silently become one of the most transformative technologies of the decade and are getting even more important. From monitoring the environment to farming, ...

Jefferies upgrades Instil Bio to "Buy" with a $52 target, anticipating significant growth for PD-(L)1xVEGF class and ...

Cleveland-Cliffs still wants to purchase all or parts of US Steel (NYSE:X) after President Joe Biden blocked its $14 billion ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, Bristol Myers Squibb's BMY.N cancer cell therapies and vaccines ...

NEW YORK (Reuters) - Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and ...